एपीए उद्धरण

Fenstermaker, R., Mechtler, L., Qiu, J., Mogensen, K., Ahluwalia, M., Adjei, A., . . . Ciesielski, M. (2014). IT-09 PHASE I STUDY OF SAFETY, TOLERABILITY AND IMMUNOLOGIC EFFECTS OF A SURVIVIN PEPTIDE MIMIC VACCINE (SurVaxM) IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA. Oxford University Press.

शिकागो स्टाइल उद्धरण

Fenstermaker, Robert, Laszlo Mechtler, Jingxin Qiu, Kathleen Mogensen, Manmeet Ahluwalia, Alex Adjei, Kelvin Lee, और Michael Ciesielski. IT-09 PHASE I STUDY OF SAFETY, TOLERABILITY AND IMMUNOLOGIC EFFECTS OF A SURVIVIN PEPTIDE MIMIC VACCINE (SurVaxM) IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA. Oxford University Press, 2014.

एमएलए उद्धरण

Fenstermaker, Robert, et al. IT-09 PHASE I STUDY OF SAFETY, TOLERABILITY AND IMMUNOLOGIC EFFECTS OF A SURVIVIN PEPTIDE MIMIC VACCINE (SurVaxM) IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA. Oxford University Press, 2014.